Follow us Facebook Icon


02 October, 2023

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

The R21/Matrix-M™ malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organization (WHO) after meeting required safety, quality and effectiveness standards. Read more...

20 August, 2023

Adar Poonawalla Receives 'Udyog Mitra' Award From Government Of Maharashtra

Serum Institute of India CEO, Adar Poonawalla received the ‘Udyog Mitra’ award from the Government Of Maharashtra. The ‘Maharashtra Industry Awards’ instituted by the Industry Department of Government of Maharashtra from this year were presented by the Hon'ble Governor of Maharashtra Ramesh Bais in Mumbai. Read more...

Cyrus Poonawalla

Dr. Cyrus S. Poonawalla

Chairman and Managing Director
Mr. Adar C. Poonawalla

Mr. Adar C. Poonawalla

Natasha Poonawalla

Mrs. Natasha A. Poonawalla

Executive Director - Serum Institute of India
Chairperson - Villoo Poonawalla Foundation


Poonawalla Group

The Cyrus Poonawalla Group of Companies headquartered in Pune, India are a diversified group with business interests that include Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation.